Alto Ingredients (ALTO) Common Equity (2010 - 2026)

Alto Ingredients (ALTO) has 17 years of Common Equity data on file, last reported at $249.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 16.81% year-over-year to $249.9 million; the trailing twelve-month figure through Mar 2026 stood at $249.9 million (up 16.81% YoY), and the FY2025 full-year result was $245.2 million, up 8.97% from the prior year.
• Common Equity for Q1 2026 stood at $249.9 million, up from $245.2 million in the prior quarter.
• Across five years, Common Equity topped out at $363.6 million in Q2 2022 and bottomed at $207.8 million in Q2 2025.
• The 5-year median for Common Equity is $268.7 million (2024), against an average of $275.6 million.
• The widest annual swing landed in 2022, when Common Equity increased 18.04%; it then declined 21.81% in 2025.
• A 5-year view of Common Equity shows it stood at $308.1 million in 2022, then slipped by 9.26% to $279.6 million in 2023, then slipped by 19.49% to $225.1 million in 2024, then gained by 8.97% to $245.2 million in 2025, then gained by 1.89% to $249.9 million in 2026.
• The last three Common Equity figures came in at $249.9 million (Q1 2026), $245.2 million (Q4 2025), and $222.4 million (Q3 2025), per Business Quant data.

Peer Comparison